SBL
CCRN icon

Sargent Bickham Lagudis’s Cross Country Healthcare CCRN Stock Holding History

Sargent Bickham Lagudis’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,000
Closed -$23K – 788
2019
Q4 		$23K Buy
+2,000
New +$22.6K ﹤0.01% 500

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Sargent Bickham Lagudis's CCRN Position: Q1 2020 in Review

Sargent Bickham Lagudis sold out of Cross Country Healthcare (CCRN) in Q1 2020, closing a stake of 2,000 shares — an estimated $23K sold.

Sargent Bickham Lagudis first reported a position in CCRN in Q4 2019 and held it in 1 quarter. The position peaked at $23K in Q4 2019. 140 funds tracked by Wall St. Rank hold CCRN as of Q1 2020.

  • Sargent Bickham Lagudis reported no remaining Cross Country Healthcare position as of Q1 2020 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 2,000 Cross Country Healthcare shares in Q1 2020, an estimated $23K.
  • Sargent Bickham Lagudis first reported a position in Cross Country Healthcare in Q4 2019 and held it in 1 quarter.
  • Sargent Bickham Lagudis's Cross Country Healthcare position peaked at $23K in Q4 2019.
  • 140 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2020.

Based on Sargent Bickham Lagudis's 13F filing for Q1 2020, filed 7 Sep 2021.